EVIDENCE FOR AUTOREGULATION OF CHOLECYSTOKININ SECRETION DURING DIVERSION OF BILE PANCREATIC-JUICE IN RATS

被引:18
作者
LI, Y [1 ]
HAO, YB [1 ]
OWYANG, C [1 ]
机构
[1] UNIV MICHIGAN,CTR MED,DEPT INTERNAL MED,GASTROENTEROL RES UNIT,ANN ARBOR,MI 48109
关键词
D O I
10.1016/0016-5085(95)90289-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The mechanism regulating cholecystokinin (CCK) secretion during prolonged diversion of bile pancreatic juice (BPJ) is unknown. We examined the hypothesis that the decrease of plasma CCK levels after prolonged diversion of BPJ is mediated by an increase in plasma somatostatin levels evoked by hypercholecystokinemia and somatostatin in turn inhibits CCK-releasing peptide (CCK-RP) bioactivity and decreases plasma CCK levels. Methods: Pancreatic secretion, plasma CCK levels, and somatostatin levels were monitored for 7 hours after diversion of BPJ in anesthetized rats. Secretion of CCK-RP bioactivity during diversion of BPJ was examined in the presence or absence of somatostatin. Results: Diversion of BPJ for 2 hours caused a 13- and 2.5-fold increase in plasma CCK and somatostatin levels. The increase in somatostatin levels was blocked by the CCK antagonist L364,718. At 5 hours after diversion of BPJ, plasma CCK and somatostatin levels and luminal CCK-RP bioactivity decreased to basal levels. The decrease in plasma CCK levels was prevented by the administration of a specific somatostatin antagonist. We also showed that the stimulatory effect of the CCK-RP bioactivity was eliminated when the donor rat was pretreated with somatostatin. Conclusions: Autoregulation of CCK secretion occurs during the diversion of BPJ and this is mediated by somatostatin, which inhibits the secretion of CCK-RP bioactivity and decreases plasma CCK levels.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 29 条
[1]   CHOLECYSTOKININ-INDUCED DESENSITIZATION OF ENZYME-SECRETION IN DISPERSED ACINI FROM GUINEA-PIG PANCREAS [J].
ABDELMOUMENE, S ;
GARDNER, JD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (04) :G272-G279
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
FOLSCH UR, 1987, GASTROENTEROLOGY, V92, P449
[4]   SOMATOSTATIN ANTAGONIST ANALOG INCREASES GH, INSULIN, AND GLUCAGON-RELEASE IN THE RAT [J].
FRIES, JL ;
MURPHY, WA ;
SUEIRASDIAZ, J ;
COY, DH .
PEPTIDES, 1982, 3 (05) :811-814
[5]  
GREEN GM, 1972, P SOC EXP BIOL MED, V140, P6, DOI 10.3181/00379727-140-36384
[6]   IMPORTANCE OF CHOLECYSTOKININ IN PEPTIDE-YY RELEASE IN RESPONSE TO PANCREATIC-JUICE DIVERSION [J].
GUAN, D ;
RIVARD, N ;
MAOUYO, D ;
GETTYS, TW ;
MORISSET, J .
REGULATORY PEPTIDES, 1993, 43 (03) :169-176
[7]   PEPTIDE-YY, A NEW PARTNER IN THE NEGATIVE FEEDBACK-CONTROL OF PANCREATIC-SECRETION [J].
GUAN, D ;
MAOUYO, D ;
TAYLOR, IL ;
GETTYS, TW ;
GREELEY, GH ;
MORISSET, J .
ENDOCRINOLOGY, 1991, 128 (02) :911-916
[8]   SOMATOSTATIN INHIBITS CCK RELEASE BY INHIBITING SECRETION AND ACTION OF CCK-RELEASING PEPTIDE [J].
HERZIG, KH ;
LOUIE, DS ;
OWYANG, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :G1156-G1161
[9]   PREPARATION AND APPLICATION OF PROCION YELLOW STARCH FOR AMYLASE ASSAY [J].
JUNG, DH .
CLINICA CHIMICA ACTA, 1980, 100 (01) :7-11
[10]   DIFFERENTIAL ACTION OF SOMATOSTATIN ON PEPTIDE-INDUCED RELEASE OF ACETYLCHOLINE [J].
KOWAL, V ;
WILEY, JW ;
OWYANG, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (02) :G221-G225